In vitro pancreatic lipase inhibition potential of Panchavalkala Aqueous and Ethanolic bark extracts.
DOI:
https://doi.org/10.70066/jahm.v10i6.587Keywords:
PVK- Panchavalkala, AE-Aqueous extract, EE- Ethanolic extract, Obesity, PL-Pancreatic lipaseAbstract
Background: Hyperlipidemia and obesity are excessive accumulation of fat in Asthayi (unstable form) and Sthayi roopa (stable form) within the body that may have deleterious health effects. One of the approached methods of treating obesity and impaired fat metabolism is inhibition of pancreatic lipase activity. Pancreatic lipase breaks down triglycerides into fatty acids which then get absorbed through the duodenal mucosa. A pancreatic lipase inhibitor prevents the formation of fatty acids and hence prevents accumulation of fats in the body. Objective: To evaluate Panchavalkala dravyas individually and together both in aqueous and ethanol extracts for inhibitory activity against pancreatic lipase. Materials and methods: In the present study, aqueous and ethanolic extracts of Nyagrodha (Ficus benghalensis L.), Udumbara (Ficus racemosa L.), Ashwatha (Ficus religiosa L.), Plaksha (Ficus virens Aiton) and Parisha (Thespesia populnea (L.)Sol.ex Correa) their mixture (1:1:1:1:1 combination) were evaluated for their inhibitory effect on Tri Acyl Glycerol Lipase enzyme using in vitro assay. In vitro pancreatic lipase inhibition activity study is carried out on both aqueous and ethanoic extracts of PVK dravyas together and on individual drugs. Orlistat is used as standard synthetic drug and caffeine as natural positive control. Results: PVK dravyas together and individually exhibited potent PL inhibitory activity except ethanoic extract of Parisha (Thespesia populnea (L.) Sol.ex Correa). Individually Ashwatha- Ficus religiosa L. EE has shown potent pancreatic lipase inhibition with an IC50 value of 18.2 μg/ml and Udumbara -Ficus racemosa L. AE shown IC50 value of 29.47μg/ml when compared to orlistat the IC50 value is 30.59μg/ml. Conclusion: The inhibitory activity was demonstrated by PVK drugs together can play a beneficial role in the treatment of hyperlipidemia and obesity.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Raghunath G V

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author(s) will retain copyright and permit the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that permits others to share the work with an acknowledgment of the author and initial publication in this journal.
The entire contents of the JAHM are protected under Indian and international copyrights. The Journal, however, allows free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute works in any online website for any non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also permits the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
In case of JAHM does not publish said work, the author(s) will be so notified and all rights assigned hereunder will be given back to the author(s).
All accepted works should not be published anywhere without prior written permission from JAHM. The author(s) hereby declare that they are sole author(s) of the work, that all authors have contributed and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work has been submitted to another journal.